83 FR 49111 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 189 (September 28, 2018)

Page Range		49111-49111
FR Document		2018-21173

Federal Register, Volume 83 Issue 189 (Friday, September 28, 2018)

[Federal Register Volume 83, Number 189 (Friday, September 28, 2018)]
[Notices]
[Page 49111]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-21173]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Neurological Sciences Training Initial Review 
Group; NST-2 Subcommittee.
    Date: October 25, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Alexandrian, 480 King Street, Alexandria, VA 22314.
    Contact Person: Elizabeth A. Webber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, (301) 496-1917, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NSD Member Conflict.
    Date: October 29, 2018.
    Time: 11:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Birgit Neuhuber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 
20892-9529, (301) 496-3562, [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Initial Review Group; Neurological Sciences and Disorders 
K.
    Date: November 5, 2018.
    Time: 8:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Shanta Rajaram, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 
20892-9529, (301) 435-6033, [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; NIH StrokeNet Clinical Trial 
Application Review.
    Date: November 5, 2018.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Marilyn Moore-Hoon, Ph.D., Scientific Review 
Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience 
Center, 6001 Executive Blvd., Suite 3285, MSC 9529, Bethesda, MD 
20892-9529, (301) 827-9087, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: September 24, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-21173 Filed 9-27-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 189 / Friday, September 28, 2018 / Notices 49111

presenting cells which are subsequently would constitute a clearly unwarranted Neurosciences, National Institutes of Health,
co-cultured with the patient’s isolated T invasion of personal privacy. HHS)
cells. Reactive T cells may be purified Name of Committee: Neurological Sciences Dated: September 24, 2018.
and expanded in vitro to generate an Training Initial Review Group; NST–2 Sylvia L. Neal,
autologous cell therapy product. The Subcommittee. Program Analyst, Office of Federal Advisory
expanded cells may be administered to Date: October 25, 2018. Committee Policy.
the patient and mediate tumor Time: 8:00 a.m. to 6:00 p.m.
[FR Doc. 2018–21173 Filed 9–27–18; 8:45 am]
regression. Agenda: To review and evaluate grant
applications. BILLING CODE 4140–01–P
This Notice is made in accordance Place: The Alexandrian, 480 King Street,
with 35 U.S.C. 209 and 37 CFR part 404. Alexandria, VA 22314.
The prospective exclusive license will Contact Person: Elizabeth A. Webber, DEPARTMENT OF HEALTH AND
be royalty bearing, and the prospective Ph.D., Scientific Review Officer, Scientific HUMAN SERVICES
exclusive license may be granted unless Review Branch, Division of Extramural
within fifteen (15) days from the date of Research, NINDS/NIH/DHHS, Neuroscience National Institutes of Health
this published Notice, the National Center, 6001 Executive Blvd., Suite 3208,
Cancer Institute receives written MSC 9529, Bethesda, MD 20892–9529, (301) National Heart, Lung, and Blood
496–1917, webbere@mail.nih.gov. Institute; Notice of Closed Meetings
evidence and argument that establishes
that the grant of the license would not Name of Committee: National Institute of
Neurological Disorders and Stroke Special Pursuant to section 10(d) of the
be consistent with the requirements of Emphasis Panel; NSD Member Conflict. Federal Advisory Committee Act, as
35 U.S.C. 209 and 37 CFR part 404. Date: October 29, 2018. amended, notice is hereby given of the
In response to this Notice, the public Time: 11:00 a.m. to 12:00 p.m. following meetings of the NHLBI
may file comments or objections. Agenda: To review and evaluate grant Special Emphasis Panel.
Comments and objections, other than applications. The meetings will be closed to the
those in the form of a license Place: National Institutes of Health, public in accordance with the
application, will not be treated Neuroscience Center, 6001 Executive provisions set forth in sections
Boulevard, Rockville, MD 20852 (Telephone
confidentially, and may be made Conference Call).
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
publicly available. Contact Person: Birgit Neuhuber, Ph.D., as amended. The grant applications and
License applications submitted in Scientific Review Officer, Scientific Review the discussions could disclose
response to this Notice will be Branch, NINDS/NIH/DHHS, Neuroscience confidential trade secrets or commercial
presumed to contain business Center, 6001 Executive Blvd., Suite 3208, property such as patentable material,
confidential information and any release MSC 9529, Bethesda, MD 20892–9529, (301) and personal information concerning
of information from these license 496–3562, neuhuber@ninds.nih.gov. individuals associated with the grant
applications will be made only as Name of Committee: National Institute of applications, the disclosure of which
Neurological Disorders and Stroke Initial would constitute a clearly unwarranted
required and upon a request under the
Review Group; Neurological Sciences and invasion of personal privacy.
Freedom of Information Act, 5 U.S.C. Disorders K.
552. Date: November 5, 2018. Name of Committee: National Heart, Lung,
Dated: September 18, 2018. Time: 8:30 a.m. to 4:30 p.m. and Blood Institute Special Emphasis Panel;
Agenda: To review and evaluate grant T4 Implementation Research for Heart, Lung,
Richard U. Rodriguez, and Blood Diseases and Sleep Disorders.
applications.
Associate Director, Technology Transfer Place: National Institutes of Health, Date: October 19, 2018.
Center, National Cancer Institute. Neuroscience Center, 6001 Executive Time: 8:00 a.m. to 3:00 p.m.
[FR Doc. 2018–21096 Filed 9–27–18; 8:45 am] Boulevard, Rockville, MD 20852 (Virtual Agenda: To review and evaluate grant
BILLING CODE 4140–01–P Meeting). applications.
Contact Person: Shanta Rajaram, Ph.D., Place: Courtyard by Marriott, 5520
Scientific Review Officer, Scientific Review Wisconsin Avenue, Chevy Chase, MD 20815.
Branch, NINDS/NIH/DHHS, Neuroscience Contact Person: Chang Sook Kim, Ph.D.,
DEPARTMENT OF HEALTH AND
Center, 6001 Executive Blvd., Suite 3208, Scientific Review Officer, Office of Scientific
HUMAN SERVICES Review/DERA, National Heart, Lung, and
MSC 9529, Bethesda, MD 20892–9529, (301)
435–6033, rajarams@mail.nih.gov. Blood Institute, 6701 Rockledge Drive, Room
National Institutes of Health 7188, Bethesda, MD 20892–7924, 301–827–
Name of Committee: National Institute of
Neurological Disorders and Stroke Special 7940, carolko@mail.nih.gov.
National Institute of Neurological
Emphasis Panel; NIH StrokeNet Clinical Trial Name of Committee: National Heart, Lung,
Disorders and Stroke; Notice of Closed and Blood Institute Special Emphasis Panel;
Application Review.
Meetings Date: November 5, 2018. NHLBI Single-Site Clinical Trials Review.
Time: 8:30 a.m. to 5:00 p.m. Date: October 23, 2018.
Pursuant to section 10(d) of the Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
Federal Advisory Committee Act, as applications. Agenda: To review and evaluate grant
amended, notice is hereby given of the Place: National Institutes of Health, applications.
following meetings. Neuroscience Center, 6001 Executive Place: Courtyard by Marriott, 5520
The meetings will be closed to the Boulevard, Rockville, MD 20852. Wisconsin Avenue, Chevy Chase, MD 20815.
public in accordance with the Contact Person: Marilyn Moore-Hoon, Contact Person: Chang Sook Kim, Ph.D.,
provisions set forth in sections Ph.D., Scientific Review Officer, Scientific Scientific Review Officer, Office of Scientific
Review Branch, NINDS/NIH/DHHS, Review/DERA, National Heart, Lung, and
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
amozie on DSK3GDR082PROD with NOTICES1

Neuroscience Center, 6001 Executive Blvd., Blood Institute, 6701 Rockledge Drive, Room
as amended. The grant applications and Suite 3285, MSC 9529, Bethesda, MD 20892– 7188, Bethesda, MD 20892–7924, 301–827–
the discussions could disclose 9529, (301) 827–9087, mooremar@ 7940, carolko@mail.nih.gov.
confidential trade secrets or commercial mail.nih.gov. (Catalogue of Federal Domestic Assistance
property such as patentable material, (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for
and personal information concerning Program Nos. 93.853, Clinical Research Sleep Disorders Research; 93.837, Heart and
individuals associated with the grant Related to Neurological Disorders; 93.854, Vascular Diseases Research; 93.838, Lung
applications, the disclosure of which Biological Basis Research in the Diseases Research; 93.839, Blood Diseases

VerDate Sep<11>2014 19:22 Sep 27, 2018 Jkt 244001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\28SEN1.SGM 28SEN1

Document Created: 2018-09-28 01:22:53
Document Modified: 2018-09-28 01:22:53

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 25, 2018.
FR Citation		83 FR 49111

83 FR 49111 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 189 (September 28, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health